Arrhythmias and Electrophysiology Center, IRCCS, Policlinico San Donato, Milan, Italy.
Circ Arrhythm Electrophysiol. 2010 Feb;3(1):32-8. doi: 10.1161/CIRCEP.109.859116. Epub 2009 Dec 7.
The purpose of this study was to provide an updated worldwide report on the methods, efficacy, and safety of catheter ablation of atrial fibrillation (AF).
A questionnaire with 46 questions was sent to 521 centers from 24 countries in 4 continents. Complete interviews were collected from 182 centers, of which 85 reported to have performed 20,825 catheter ablation procedures on 16,309 patients with AF between 2003 and 2006. The median number of procedures per center was 245 (range, 2 to 2715). All centers included paroxysmal AF, 85.9% also included persistent and 47.1% also included long-lasting AF. Carto-guided left atrial circumferential ablation (48.2% of patients) and Lasso-guided ostial electric disconnection (27.4%) were the most commonly used techniques. Efficacy data were analyzed with centers representing the unit of analysis. Of 16,309 patients with full disclosure of outcome data, 10 488 (median, 70.0%; interquartile range, 57.7% to 75.4%) became asymptomatic without antiarrhythmic drugs and another 2047 (10.0%; 0.5% to 17.1%) became asymptomatic in the presence of previously ineffective antiarrhythmic drugs over 18 (range, 3 to 24) months of follow-up. Success rates free of antiarrhythmic drugs and overall success rates were significantly larger in 9590 patients with paroxysmal AF (74.9% and 83.2%) than in 2800 patients with persistent AF (64.8% and 75.0%) and 1108 patients with long-lasting AF (63.1% and 72.3%) (P<0.0001). Major complications were reported in 741 patients (4.5%).
When analyzed in a large number of electrophysiology laboratories worldwide, catheter ablation of AF shows to be effective in approximately 80% of patients after 1.3 procedures per patient, with approximately 70% of them not requiring further antiarrhythmic drugs during intermediate follow-up.
本研究的目的是提供一份关于房颤(AF)导管消融的方法、疗效和安全性的全球最新报告。
向来自四大洲 24 个国家的 521 个中心发送了一份包含 46 个问题的问卷。从 182 个中心中收集到了完整的访谈,其中 85 个中心报告称,在 2003 年至 2006 年间,对 16309 名房颤患者进行了 20825 次导管消融治疗。每个中心的中位数为 245 次(范围:2 至 2715 次)。所有中心均包括阵发性房颤,85.9%的中心还包括持续性房颤,47.1%的中心还包括持久性房颤。环肺静脉左心房消融(48.2%的患者)和 Lasso 引导的开口电分离(27.4%)是最常用的技术。疗效数据以中心为单位进行分析。在对 16309 名患者的全部结果数据进行披露后,10488 名(中位数,70.0%;四分位距,57.7%至 75.4%)在无抗心律失常药物的情况下无症状,另有 2047 名(10.0%;0.5%至 17.1%)在服用之前无效的抗心律失常药物 18 个月(范围,3 至 24 个月)后无症状。9590 名阵发性房颤患者(74.9%和 83.2%)的无抗心律失常药物成功率和总成功率明显大于 2800 名持续性房颤患者(64.8%和 75.0%)和 1108 名持久性房颤患者(63.1%和 72.3%)(P<0.0001)。741 名患者(4.5%)报告了主要并发症。
在全球大量电生理实验室进行分析时,房颤导管消融术显示,在每位患者进行 1.3 次治疗后,约有 80%的患者有效,其中约 70%的患者在中期随访期间无需进一步使用抗心律失常药物。